Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic. | Curr Oncol | 2022 | 35621648 | PubTator, text mining | PubMed |
| Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes. | Front Genet | 2022 | 35620468 | PubTator, text mining | PubMed |
| iUMRG: multi-layered network-guided propagation modeling for the inference of susceptibility genes and potential drugs against uveal melanoma. | NPJ Syst Biol Appl | 2022 | 35610253 | PubTator, text mining | PubMed |
| Klippel-Trenaunay Syndrome: Case series from a university hospital of Nepal. | Ann Med Surg (Lond) | 2022 | 35600200 | PubTator, text mining | PubMed |
| Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits. | ACS Pharmacol Transl Sci | 2022 | 35592437 | PubTator, text mining | PubMed |
| Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing. | Front Endocrinol (Lausanne) | 2022 | 35586626 | PubTator, text mining | PubMed |
| In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations. | Eur J Cancer | 2022 | 35580369 | PubTator, text mining | PubMed |
| Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis. | Front Oncol | 2022 | 35574390 | PubTator, text mining | PubMed |
| Acquired Compound Melanocytic Nevus on the Palate of a Child: Report of a Case. | J Oral Maxillofac Res | 2022 | 35574207 | PubTator, text mining | PubMed |
Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors. | Ann Diagn Pathol | 2022 | 35567887 | PubTator, text mining | PubMed |
| Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy. | J Clin Med | 2022 | 35566721 | PubTator, text mining | PubMed |
| Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival. | Cancers (Basel) | 2022 | 35565222 | PubTator, text mining | PubMed |
| Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation. | Oncologist | 2022 | 35552752 | PubTator, text mining | PubMed |
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome. | J Immunother Cancer | 2022 | 35550553 | PubTator, text mining | PubMed |
| Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism. | Eur J Endocrinol | 2022 | 35521792 | PubTator, text mining | PubMed |
| The future of targeted kinase inhibitors in melanoma. | Pharmacol Ther | 2022 | 35513054 | PubTator, text mining | PubMed |
| MITF deficiency accelerates GNAQ-driven uveal melanoma. | Proc Natl Acad Sci U S A | 2022 | 35512098 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene. | Ital J Pediatr | 2022 | 35509048 | PubTator, text mining | PubMed |
| Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena. | J Hematol Oncol | 2022 | 35505417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=36